ev3’s Protégé Joins Sprouting Field In U.S. Carotid Stent Market
This article was originally published in The Gray Sheet
Executive Summary
Plymouth, Minn.-based ev3 Inc. joined a growing number of players in the U.S. carotid stent market with the Jan. 25 nationwide launch of its Protégé RX immediately following FDA approval